All In MedTech

Device Trial Radar · NCT06492746

Personal BP - CAI Study

Assessing for Personalized Blood Pressure Targets During Cardiopulmonary Bypass With the Proprietary Cerebral Adaptive Index: A Pilot Investigation

Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jun 3, 2024

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Becton, Dickinson and CompanyPublic (BDX)
Sponsor type
Industry
First posted
Jul 9, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets

Conditions

  • Blood Pressure

Interventions

  • HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry MonitoringDevice

    The arterial line with Acumen IQ sensor and Foresight Elite sensor will be connected to the HemoSphere monitor with laptop displaying the CAI parameter.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To determine the magnitude and duration of CAITime frame: Duration of the procedure through 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northwestern University Hospital

    Evanston, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.